HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Accepted manuscript (PDF) All Versions of this Article: JOE-08-0549v1 202/1/1    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schneyer, A. Articles by Xia, Y. Search for Related Content PubMed PubMed Citation Articles by Schneyer, A. Articles by Xia, Y.

A Schneyer, Endocrinology and Metabolism, Pioneer Valley Life Science Institute, Springrield, 01107, United States
Y Xia, Program in Membrane Biology and Division of Nephrology, Massachusetts General Hospital, Boston, United States

Correspondence: Alan Schneyer, Email: Alan.Schneyer{at}bhs.org

Abstract

Activin was discovered in the 1980s as a gonadal protein that stimulated FSH release from pituitary gonadotropes and was thought of as a reproductive hormone. In the ensuing decades many additional activities of activin were described and it was found to be produced in a wide variety of cell types at nearly all stages of development. Its signaling and actions are regulated intracellularly as well as by extracellular antagonists. Over the past 5 years a number of important advances have been made that clarify our understanding of the structural basis for signaling and regulation, as well as the biological roles of activin in stem cells, embryonic development, and in adults. These include the crystallization of activin in complex with the activin type II receptor ActRIIB, or with the binding proteins follistatin and follistatin-like 3 (FSTL3), and identification of the activin roles in gonadal sex development, follicle development and luteolysis, in beta-cell proliferation and function in the islet, in stem cell self-renewal and differentiation into different cell types, and in immune cells. These advances are reviewed to provide perspective for future studies.

This article has been cited by other articles:

				M. Semitekolou, T. Alissafi, M. Aggelakopoulou, E. Kourepini, H. H. Kariyawasam, A. B. Kay, D. S. Robinson, C. M. Lloyd, V. Panoutsakopoulou, and G. Xanthou Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease J. Exp. Med., August 3, 2009; 206(8): 1769 - 1785. [Abstract] [Full Text] [PDF]

				E. A Garcia, P. King, K. Sidhu, H. Ohgusu, A. Walley, C. Lecoeur, M. Gueorguiev, S. Khalaf, D. Davies, A. B Grossman, et al. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes Eur. J. Endocrinol., August 1, 2009; 161(2): 307 - 315. [Abstract] [Full Text] [PDF]